InNexus Biotechnology (InNexus Biotechnology) Interest Coverage : 0 (At Loss) (As of Mar. 2011)

InNexus Biotechnology Interest Coverage Chart

InNexus Biotechnology Annual Data
	Trend	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09	Jun10
Interest Coverage		Get a 7-Day Free Trial					No Debt	No Debt	-	-	-

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Interest Coverage	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of InNexus Biotechnology's Interest Coverage

For the Biotechnology subindustry, InNexus Biotechnology's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InNexus Biotechnology's Interest Coverage Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's Interest Coverage distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's Interest Coverage falls into.

InNexus Biotechnology Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Else if Interest Expense is negative and Operating Income is negative, then

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

InNexus Biotechnology's Interest Coverage for the fiscal year that ended in Jun. 2010 is calculated as

Here, for the fiscal year that ended in Jun. 2010, InNexus Biotechnology's Interest Expense was $-2.69 Mil. Its Operating Income was $-3.79 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

InNexus Biotechnology's Interest Coverage for the quarter that ended in Mar. 2011 is calculated as

Here, for the three months ended in Mar. 2011, InNexus Biotechnology's Interest Expense was $-0.25 Mil. Its Operating Income was $-0.32 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

InNexus Biotechnology  (GREY:IXSBF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

InNexus Biotechnology Interest Coverage Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description